Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.A US appeals court has upheld a lower court decision allowing Bayer agreement that paid Barr Pharmaceuticals to delay manufacturing a generic version of the antibiotic drug Cipro, reported Reuters.
Subscribe to our email newsletter
The US Court of Appeals for the Federal Circuit has reportedly affirmed the ruling by the US District Court of New York.
The source has also cited a difference of opinion between the Federal Trade Commission (FTC) and the courts over agreements that delay the availability of cheaper generic versions of drugs. While the FTC considers such agreements as a breach of antitrust law, the courts think otherwise.